Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16,681,212
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1,351,642
-
Shares change
-
+249,793
-
Total reported value, excl. options
-
$5,500,530
-
Value change
-
+$1,016,460
-
Number of buys
-
10
-
Number of sells
-
-1
-
Price
-
$4.07
Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q2 2023
13 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,351,642 shares
of 16,681,212 outstanding shares and own 8.1% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (586,872 shares), GREENLIGHT CAPITAL INC (392,647 shares), Worth Venture Partners, LLC (146,493 shares), CM Management, LLC (60,000 shares), GEODE CAPITAL MANAGEMENT, LLC (58,573 shares), BANK OF AMERICA CORP /DE/ (46,052 shares), UBS Group AG (26,602 shares), Mirador Capital Partners LP (15,361 shares), CITADEL ADVISORS LLC (10,537 shares), and BlackRock Inc. (7,433 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.